Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study
Clinical trial NCT06240195 · RECRUITING
Trial details
- NCT number
- NCT06240195
- Sponsor
- Regina Elena Cancer Institute
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-17
- Primary completion
- 2025-01-17
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.